Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal vs Subcutaneous Adalimumab in Non-infectious Uveitis
NCT02706704Phase 2Terminated
- Sponsor
- American University of Beirut Medical Center
- Start
- Feb 2016
- Primary completion
- Jan 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in noninfectious uveitis (NIU), sponsored by American University of Beirut Medical Center. Started Feb 2016; status: terminated.
02
Drugs
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT02706704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706704.